News

May 10, 2017May 10, 2017

Clinical Trial to Assess Vigabatrin for Preventing or Delaying Seizures in Children with Tuberous Sclerosis

News

Texas-led researchers are recruiting children for a Phase 2b clinical trial that will investigate whether vigabatrin can prevent or delay the onset of epileptic seizures in youngsters with tuberous sclerosis. ... Read more

May 8, 2017May 9, 2017

Investigational Epilepsy Therapy for Children Shows Targeted Potential in Early Testing

News

Preclinical studies on The Cell Factory’s lead investigational biologic drug (CF-MEV-117) for the treatment of drug-resistant epilepsy in children has been shown to have dose-dependent anti-inflammatory and immunosuppressive activity. These ... Read more

May 5, 2017May 5, 2017

Anxiety, Depression More Prevalent Among Epileptics, Study Finds

News

Epileptics frequently suffer from anxiety and depression, but experts aren’t completely sure why, according to a recent study. The study, “Anxiety and Depressive Disorders in People with Epilepsy: A Meta-Analysis” ... Read more

May 3, 2017

Zogenix Completes Enrollment for Phase 3 Trial of ZX008 as Dravet Syndrome Therapy

News

Zogenix has completed patient enrollment for the Phase 3 Study 1 trial (NCT02826863) of ZX008 as an add-on therapy for seizures in children and young adults with Dravet syndrome. “The ... Read more

April 28, 2017May 4, 2017

Fycompa Effective as Add-on Antiepileptic Drug in Patients with Tonic-Clonic Seizures, Data Suggests

News

Eisai recently presented data in Boston showing that the effect of its epilepsy treatment, Fycompa, and other antiepileptic drugs (AEDs) against primary generalized tonic-clonic seizures seems to be similarly positive in children and adults. The ... Read more

April 26, 2017

Obesity During Pregnancy Boosts Risk of Childhood Epilepsy, Study Finds

News

Maternal obesity may lead to increased rates of childhood epilepsy. That is the finding of researchers in Sweden who conducted the study “Maternal Body Mass Index in Early Pregnancy and ... Read more

April 24, 2017

Cannabis Media Group Promotes RSHO-X Cannabidiol Oil for Epilepsy

News

The medical cannabis product cannabidiol oil — marketed as RSHO-X — is showing promise as an epilepsy treatment, according to CFN Media Group. The digital media network, dedicated to legal ... Read more

April 21, 2017

Zika Virus May Trigger Epilepsy, CDC Researchers Caution in Report

News

In addition to its well-known links to birth defects, Zika virus infection during pregnancy can cause epilepsy, according to a report from the U.S. Centers for Disease Control and Prevention ... Read more

April 19, 2017April 19, 2017

GW’s Cannabinoid Therapy Epidiolex Shows Promise in Treating Children with Lennox-Gastaut Syndrome

News

Children with Lennox-Gastaut syndrome (LGS) who were treated with the cannabinoid product Epidiolex (cannabidiol) had fewer drop seizures, according to results of a clinical trial developed by Britain’s GW Pharmaceuticals. The Phase 3 ... Read more

April 17, 2017

Eisai Presentation to Include Possible Use of Epilepsy Therapy Fycompa in Children

News

Eisai Inc. will make a presentation in Boston this month on its epilepsy treatment Fycompa CIII‘s effectiveness against a range of seizure types. Company researchers involved in the presentation at the annual meeting of the ... Read more